• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋病:最新情况

Gonorrhea: update.

作者信息

Little James W

机构信息

University of Minnesota, Naples, FL, USA.

出版信息

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Feb;101(2):137-43. doi: 10.1016/j.tripleo.2005.05.077.

DOI:10.1016/j.tripleo.2005.05.077
PMID:16448912
Abstract

Gonorrhea is a worldwide sexually transmitted disease (STD) caused by Neisseria gonorrhoeae. Gonorrhea is the second most often reported STD in the United States behind chlamydia. An estimated 600,000 people each year in the United States are infected. Only about half this number of cases are reported. From 1975 through 1997, the national gonorrhea rate declined 74.3%. After a small increase in 1998, the gonorrhea rate has decreased each year since 1999. In 2003 the South had the highest gonorrhea rate among the four regions of the country. Antimicrobial resistance remains an important consideration in the treatment of gonorrhea. In 2003 the Gonococcal Isolate Surveillance Project found about 16% of collected isolates were resistant to penicillin and/or tetracycline. Since 1998 the number of ciprofloxacin-resistant isolates has been increasing with 270 (4.1%) being reported in 2003. Oral gonorrhea is rare, nonspecific, and varied and may range from slight erythema to severe ulceration with a pseudomembranous coating. The patient with gonorrhea poses little threat of disease transmission to the dentist. However, patients who have or have had gonorrhea should be approached with a measure of caution because they are in a high-risk group for additional STDs. The CDC has published recommendations for standard precautions to be followed in controlling infection in dentistry that have become the standard for preventing cross-infection. Strict adherence to these recommendations will, for all practical purposes, eliminate the danger of disease transmission between dentist and patient. Dentists should be aware of local statutory requirements regarding reporting STDs to state health officials. Syphilis, gonorrhea, and AIDS are reportable diseases in every state. Local health departments or state STD programs are sources of information regarding this matter.

摘要

淋病是一种由淋病奈瑟菌引起的全球性性传播疾病(STD)。淋病是美国报告率仅次于衣原体感染的第二常见性传播疾病。据估计,美国每年有60万人感染淋病。而报告的病例数仅约为这一数字的一半。从1975年到1997年,全国淋病发病率下降了74.3%。1998年略有上升后,自1999年以来淋病发病率逐年下降。2003年,美国南部地区的淋病发病率在全国四个地区中最高。抗菌药物耐药性仍是淋病治疗中的一个重要考虑因素。2003年,淋病分离株监测项目发现,约16%的收集分离株对青霉素和/或四环素耐药。自1998年以来,对环丙沙星耐药的分离株数量一直在增加,2003年报告了270株(4.1%)。口腔淋病罕见、无特异性且表现多样,可能从轻微红斑到伴有假膜覆盖的严重溃疡不等。淋病患者对牙医造成疾病传播的威胁很小。然而,患有或曾患淋病的患者应谨慎对待,因为他们属于其他性传播疾病的高危人群。美国疾病控制与预防中心(CDC)发布了牙科控制感染应遵循的标准预防措施建议,这些建议已成为预防交叉感染的标准。实际上,严格遵守这些建议将消除牙医与患者之间疾病传播的危险。牙医应了解向州卫生官员报告性传播疾病的当地法定要求。梅毒、淋病和艾滋病在每个州都是应报告的疾病。当地卫生部门或州性传播疾病项目是关于此事的信息来源。

相似文献

1
Gonorrhea: update.淋病:最新情况
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Feb;101(2):137-43. doi: 10.1016/j.tripleo.2005.05.077.
2
Trends of sexually transmitted diseases and antimicrobial resistance in Neisseria gonorrhoeae.淋病奈瑟菌的性传播疾病趋势及抗菌药物耐药性
Int J Antimicrob Agents. 2008 Feb;31 Suppl 1:S35-9. doi: 10.1016/j.ijantimicag.2007.08.029.
3
Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections.美国疾病预防控制中心性传播疾病治疗指南更新,2010 年:口服头孢菌素不再作为淋球菌感染的推荐治疗方法。
MMWR Morb Mortal Wkly Rep. 2012 Aug 10;61(31):590-4.
4
Increases in fluoroquinolone-resistant Neisseria gonorrhoeae among men who have sex with men--United States, 2003, and revised recommendations for gonorrhea treatment, 2004.美国2003年男男性行为者中耐氟喹诺酮淋病奈瑟菌感染增加情况及2004年淋病治疗的修订建议
MMWR Morb Mortal Wkly Rep. 2004 Apr 30;53(16):335-8.
5
National surveillance of antimicrobial susceptibility in Neisseria gonorrhoeae in 2005-2006 and recommendations of first-line antimicrobial drugs for gonorrhoea treatment in Russia.2005 - 2006年俄罗斯淋病奈瑟菌抗菌药物敏感性的全国监测及淋病治疗一线抗菌药物的建议
Sex Transm Infect. 2008 Aug;84(4):285-9. doi: 10.1136/sti.2007.029033. Epub 2008 Feb 6.
6
Sexually transmitted diseases among adolescents in developed countries.发达国家青少年中的性传播疾病
Fam Plann Perspect. 2000 Jan-Feb;32(1):24-32, 45.
7
Adherence to CDC Recommendations for the Treatment of Uncomplicated Gonorrhea - STD Surveillance Network, United States, 2016.美国性传播疾病监测网络 2016 年对无并发症淋病治疗中遵循 CDC 建议的情况。
MMWR Morb Mortal Wkly Rep. 2018 Apr 27;67(16):473-476. doi: 10.15585/mmwr.mm6716a4.
8
Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections.美国疾病控制与预防中心《2006年性传播疾病治疗指南》更新内容:不再推荐使用氟喹诺酮类药物治疗淋球菌感染。
MMWR Morb Mortal Wkly Rep. 2007 Apr 13;56(14):332-6.
9
European Surveillance of Sexually Transmitted Infections (ESSTI): the first combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe.欧洲性传播感染监测(ESSTI):西欧淋病奈瑟菌的首批联合抗菌药物敏感性数据。
J Antimicrob Chemother. 2006 Sep;58(3):587-93. doi: 10.1093/jac/dkl265. Epub 2006 Jul 1.
10
Antimicrobial resistance pattern of Neisseria gonorrhoeae isolates from peripheral health centres and STD clinic attendees of a tertiary care centre in India.印度一家三级医疗中心周边健康中心及性传播疾病门诊患者中分离出的淋病奈瑟菌菌株的抗菌药物耐药模式。
Int J STD AIDS. 2008 Jun;19(6):378-80. doi: 10.1258/ijsa.2007.007226.

引用本文的文献

1
A Review of Recent Advances in Our Understanding of Neisseria gonorrhoeae.淋病奈瑟菌认识进展的近期综述
Cureus. 2023 Aug 14;15(8):e43464. doi: 10.7759/cureus.43464. eCollection 2023 Aug.
2
Mechanisms of host manipulation by .由……进行宿主操控的机制 。 你提供的原文不完整,“by”后面缺少具体内容。
Front Microbiol. 2023 Feb 3;14:1119834. doi: 10.3389/fmicb.2023.1119834. eCollection 2023.
3
In vivo efficacy of acetazolamide in a mouse model of Neisseria gonorrhoeae infection.乙酰唑胺在淋病奈瑟菌感染小鼠模型中的体内疗效。
Microb Pathog. 2022 Mar;164:105454. doi: 10.1016/j.micpath.2022.105454. Epub 2022 Feb 19.
4
Structure-Activity Relationship Studies of Acetazolamide-Based Carbonic Anhydrase Inhibitors with Activity against .基于乙酰唑胺的碳酸酐酶抑制剂与. 的活性的构效关系研究
ACS Infect Dis. 2021 Jul 9;7(7):1969-1984. doi: 10.1021/acsinfecdis.1c00055. Epub 2021 Mar 25.
5
Epithelial Haven and Autophagy Breakout in Gonococci Infection.淋球菌感染中的上皮避难所与自噬突破
Front Cell Dev Biol. 2020 Jun 9;8:439. doi: 10.3389/fcell.2020.00439. eCollection 2020.
6
Gonococcal conjunctivitis after incomplete treatment of gonococcal urethritis.淋菌性尿道炎治疗不彻底后发生的淋菌性结膜炎。
Infect Drug Resist. 2019 May 23;12:1381-1384. doi: 10.2147/IDR.S199163. eCollection 2019.
7
Neisseria gonorrhoeae host adaptation and pathogenesis.淋病奈瑟菌的宿主适应和发病机制。
Nat Rev Microbiol. 2018 Apr;16(4):226-240. doi: 10.1038/nrmicro.2017.169. Epub 2018 Feb 12.
8
Neisseria prophage repressor implicated in gonococcal pathogenesis.淋病奈瑟菌噬菌体阻遏物与淋病发病机制相关。
Infect Immun. 2013 Oct;81(10):3652-61. doi: 10.1128/IAI.00298-13. Epub 2013 Jul 22.
9
Bacterial and viral pathogens in saliva: disease relationship and infectious risk.唾液中的细菌和病毒病原体:疾病关系与感染风险。
Periodontol 2000. 2011 Feb;55(1):48-69. doi: 10.1111/j.1600-0757.2010.00361.x.